Sector: MedicalMerck & Company, Inc. (NYSE: MRK)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 243 |
Technical : | 88 |
Performance : | 196 |
Overall: | 204 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 240 |
Technical : | 101 |
Performance : | 213 |
Overall: | 220 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 238 |
Technical : | 61 |
Performance : | 207 |
Overall: | 201 |
Number of Stocks: | 306 |
Headlines
- Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R)
Nov 20, 2009 08:07 AM | MRK
- Ligand Earns $2 Million in Milestone Payments from Merck & Co., Inc.
Nov 19, 2009 08:30 AM | BMY, CELG, GSK, LGND, MRK
- Dispensary of Hope Partners with Leading Pharma Companies to Expand Prescription Medications Access to Tennesseans in Need
Nov 18, 2009 05:09 PM | AZN, MRK, NVS
- Article One Partners Becomes World's Largest Patent Validation Firm
Nov 18, 2009 08:02 AM | MRK
- Beazer, Merck, Citigroup, Lowe's, Apollo Group are among big market movers Monday
Nov 17, 2009 01:31 PM | APOL, BZH, C, ITW, LNY, LOW
- Merck's Investigational Anacetrapib Phase IIb Study Results Presented at American Heart Association Annual Scientific Sessions
Nov 17, 2009 09:00 AM | MRK
- Higher Dose of Merck's COZAAR(R) (losartan potassium tablets) Significantly Reduced Deaths and Hospitalizations Due to Heart Failure In Investigational Study
Nov 17, 2009 08:00 AM | MRK
- Applied Materials, Merck and Braunschweig University Awarded Funding by German Government for OLED Research
Nov 17, 2009 07:30 AM | AMAT, MRK
- RidgewaterEquity.com Free Fundamental Sector & Market Research on STI, MRK, HP, THC, NVAX and NVLS
Nov 17, 2009 06:54 AM | HP, HPQ, MRK, STI, THC
- Merck Expresses Confidence in the Efficacy and Safety Profiles of ZETIA(R) (ezetimibe) and VYTORIN(R) (ezetimibe/simvastatin) as Effective Medicines for Managing Elevated Cholesterol
Nov 15, 2009 06:12 PM | MRK
- Study: Niacin, statins better than Zetia
Nov 16, 2009 10:17 AM | MRK
- Drug industry raises prices by 9 percent
Nov 16, 2009 09:40 AM | MRK
- Business Highlights
Nov 02, 2009 06:52 PM | BDK, CIT, HUM, MRK, PFE, SGP
- Feds side with investors in Vioxx suit
Nov 02, 2009 04:59 PM | MRK
- Schering-Plough Shares Hit Premerger Bump -- Fails Expectations, but Merck Deal Encouraging
Oct 23, 2009 05:51 PM | MRK, SGP
- Schering-Plough Shares Hit Premerger Bump
Oct 23, 2009 05:54 AM | MRK, SGP, TRI
- Bristol-Myers posts higher 3Q sales, lower profit
Oct 22, 2009 02:53 PM | MRK, PFE, SGP
- Schering-Plough posts 17 percent drop in 3Q profit
Oct 22, 2009 11:53 AM | JNJ, MRK
- Schering-Plough posts 17 percent drop in 3Q profit
Oct 22, 2009 07:51 AM | JNJ, MRK
- Earnings Preview: Bristol-Myers 3Q earnings report
Oct 21, 2009 11:53 AM | AZN, BMY, GSK, JNJ, LLY, MRK
- Market Watch: Sunwin International Neutraceuticals - November 10, 2009
Nov 10, 2009 09:51 AM | BAC, MRK, SUWN, TEVA
- Merck and Schering-Plough to Complete Merger Today
Nov 03, 2009 11:51 AM | MRK, SGP
- Corporate Office Properties Trust Reports Third Quarter 2009 Results
Oct 28, 2009 05:53 PM | BA, CIEN, CMCSA, CSC, GD, ISYS
- Ev3 Reports 2009 Third Quarter Financial Results
Oct 27, 2009 06:52 AM | MRK
- Merck Announces Third-Quarter 2009 Financial Results
Oct 22, 2009 07:51 AM | AZN, MRK
- Global Health Ventures Inc. (OTCBB: GHLV) Commences an Investment Road Show, Starting in Montreal, Quebec and Then Presenting in London, England
Oct 06, 2009 04:52 PM | GSX, MRK, PFE, SNY
- UBS Investment Bank Strengthens Healthcare Banking Team By Hiring Four Managing Directors
Sep 16, 2009 04:51 PM | IMA, MRK, TWPG
- Stock in Focus: Sunwin International Neutraceuticals -- September 16, 2009
Sep 16, 2009 09:51 AM | BCRX, MRK, PFE, SUWN
- GTx Inc. (GTXI) Chief Executive Officer to Ring The NASDAQ Stock Market Opening Bell
Sep 09, 2009 04:17 PM | GTXI, MRK, NDAQ
- Merck Wins SINGULAIR® Patent Infringement Lawsuit
Aug 19, 2009 10:53 AM | MRK
- Form 4 Merck & Co. Inc. For: Nov 03 Filed by: LAZARUS ROCHELLE B (10K)
Nov 16, 2009 11:46 AM
- Form 4 KOHAN RAUL E For: Nov 03 (10K)
Nov 09, 2009 01:19 PM
- Form 4 Turner Mervyn For: Nov 03 (10K)
Nov 09, 2009 11:43 AM
- Form 4 Bowles Richard S III For: Nov 03 (10K)
Nov 06, 2009 07:44 PM
- Form 4 BARSHAY STANLEY F For: Nov 03 (10K)
Nov 06, 2009 04:32 PM
- Form 4 KIDDER C ROBERT For: Nov 03 (10K)
Nov 06, 2009 03:44 PM
- Form 4 RUSSO PATRICIA F For: Nov 03 (10K)
Nov 06, 2009 01:15 PM
- Form 4 Thompson Craig B. For: Nov 03 (10K)
Nov 05, 2009 10:37 PM
- Form 4 Merck & Co. Inc. For: Nov 03 Filed by: WENDELL PETER C (10K)
Nov 05, 2009 10:22 PM
- Form 4 Merck & Co. Inc. For: Nov 03 Filed by: TATLOCK ANNE M (10K)
Nov 05, 2009 10:18 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MRK
|
Compare to S&P
|
| YTD |
8.88 %
|
-10.06 %
|
| 4 Weeks |
-0.33 %
|
-0.86 %
|
| 12 Weeks |
1.66 %
|
-4.60 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 8.43 %
|
|
EPS Growth in Last Year: 12.50 %
|
|
Sales Growth in Last Quarter: 2.54 %
|
|
Sales Growth in Last Quarter: 1.78 %
|
|
